高级搜索

RASSF1A基因对肝癌细胞化疗药物敏感性的影响

Effects of RASSF1A Expression on Chemosensitivity of Hepatocellular Carcinoma Cell

  • 摘要: 目的 探讨RASSF1A基因的表达对肝细胞肝癌化疗药物敏感性的影响。 方法 利用已构建成功的稳定表达野生型和突变型RASSF1A基因的肝癌细胞株QGY-7703,化疗药物Mitomycin、Adriamycin、Etoposide、5-Fluorouracilur、Cisplatin分别作用各细胞株后,比较生长抑制率、细胞周期及P53、P21、Bax、Caspase-3蛋白的表达水平。 结果 野生型RASSF1A的表达可提高Mitomycin诱导的肝癌细胞生长抑制率、凋亡发生率(P<0.05)和Caspase-3的活性,对P53、P21、Bax基因的蛋白表达水平没有影响。 结论 野生型RASSF1A基因可提高肝癌细胞对Mitomycin的敏感性。

     

    Abstract: Objective To explore the effect of RASSF1A on the chemosensitivity of human hepatocellular carcinoma (HCC) cell line QGY-7703. Methods The QGY-7703 cells expressing RASSF1A gene (wild type or mutant) stably were used in this study. The cells were treated with the antitumor drugs including Mitomycin, Adriamycin, Etoposide, 5-Fluorouracilur and Cisplatin. Then the rate of cell growth inhibition, changes of cell cycle and expression levels of p53, p21, bax and caspase-3 were measured. Results Expression of wild-type RASSF1A in the QGY-7703 cells could enhance the rate of cell growth inhibition, the percentage of apoptotic cells and caspase-3 activity compared with the cells that express mutant RASSF1A after those cells were treated with Mitomycin(P<0.05). No significant differences of expression levels of the Bax, p53 and p21 protein were observed among those cells. Conclusion Wild-type RASSF1A expression could increase chemosensitivity of QGY-7703 cells to Mitomycin.

     

/

返回文章
返回